Lydtin, 1989 - Google Patents
Sekundärprophylaxe des HerzinfarktesLydtin, 1989
- Document ID
- 596833762499548531
- Author
- Lydtin H
- Publication year
- Publication venue
- Verhandlungen der Deutschen Gesellschaft für Innere Medizin: Kongreß gehalten zu Wiesbaden vom 2. bis 6. April 1989
External Links
Snippet
Sekundärprophylaxe beginnt mit dem Erstinfarkt—bzw. einer anderen Erstmanifestation der koronaren Herzkrankheit wie zB einer Angina pectoris oder dem elektrokardiographischen Nachweis einer stummen Myokardischämie [Wikstrand et al. 1988]—und zielt wie die …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69326014T2 (en) | DITHIOCARBAMATE FOR THE TREATMENT OF ATHEROSKEROSIS AND OTHER CARDIOVASCULAR AND INFLAMMABLE DISEASES | |
| Tartara et al. | Vigabatrin in the treatment of epilepsy: a double‐blind, placebo‐controlled study | |
| Hoeschen | Oxidative stress and cardiovascular disease | |
| DE69519937T2 (en) | POLYAMINE COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | |
| EP0935461B1 (en) | Adamantane amine derivatives for the treatment of viruses of the bornaviridae family | |
| Levine et al. | Long-term fluoxetine treatment of a large number of obsessive-compulsive patients | |
| EP4135701A1 (en) | Use of coenzyme antagonists in order to slow down a metabolic process | |
| DE69936307T2 (en) | REDUCTION OF HOMOCYSTONE CONCENTRATION IN THE SERUM BY ALLIUM AND VITAMINS | |
| Lehrman et al. | Effect of coronary arterial bypass surgery on exercise-induced ventricular arrhythmias: Long-term follow-up of a prospective randomized study | |
| Lydtin | Sekundärprophylaxe des Herzinfarktes | |
| Bauer et al. | Erstnachweis von Oxyopes lineatus in Deutschland und faunistisch-taxonomische Anmerkungen zu weiteren besonderen Arten aus Baden-Württemberg (Araneae: Lycosidae, Oxyopidae, Salticidae, Thomisidae, Trachelidae). | |
| Marciani et al. | Effect of carbamazepine on EEG background activity and on interictal epileptiform abnormalities in focal epilepsy | |
| Dow et al. | The effects of some anticonvulsant drugs on cobalt‐induced epilepsy | |
| DE60305534T2 (en) | USE OF DOCOSAHEXAENIC ACID AS ACTIVE IN THE TREATMENT OF LIPODYSTROPHY | |
| DE19726871C1 (en) | Synergistic compositions for the selective control of tumor tissue | |
| Adamec et al. | Power spectral analysis of EEG drug response in the kindled rat brain | |
| EP1879609B1 (en) | Use of histones for therapeutic purposes | |
| DE69936773T2 (en) | TREATMENT OF DEPRESSION AND COMPOSITIONS THEREOF | |
| Kale | Clinical trials of amodiaquine in onchocerciasis | |
| EP0241498B1 (en) | Analgesic and anti-inflammatory medicine made from plants | |
| Eschenhagen | Antiarrhythmika | |
| von Leitner | Nicht-invasive Verfahren einschließlich Holter-Monitoring | |
| Imafidon et al. | Protective Effect of Ethanolic Extract of Palisota hirsuta on CCl4 Induced Hepatotoxicity | |
| HOLLISTER et al. | Serum oxidase activity in chronic schizophrenics treated with tranquilizing drugs | |
| Klose et al. | Lipidsenkende Mittel |